Financial News · Live Terminal

Page 11 of 156

Nurix Therapeutics Insider Sold Shares Worth $382,358, According to a Recent SEC Filing

Christine Ring, Chief Legal Officer, on August 03, 2026, sold 16,589 shares in Nurix Therapeutics (NRIX) for $382,358. Following the Form 4 filing with the SEC, Ring has control over a total of 9,110 common shares of the company, with 9,110 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1549595/000181719926000028/xslF345X05/wk-form4_1785793916.xml

$NRIX

Insider Trading4d ago

Freeport-Mcmoran Insider Sold Shares Worth $475,650, According to a Recent SEC Filing

Stephen T. Higgins, Executive Vice President and Chief Administrative Officer, on July 30, 2026, sold 7,550 shares in Freeport-Mcmoran (FCX) for $475,650. Following the Form 4 filing with the SEC, Higgins has control over a total of 126,989 common shares of the company, with 40,333 shares held directly and 86,656 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/831259/000121465926009498/xslF345X05/marketforms-73649.xml

$FCX

Insider Trading4d ago

F5 Insider Sold Shares Worth $1,555,795, According to a Recent SEC Filing

Nikhil Ramesh Mehta, Director, on July 30, 2026, sold 4,000 shares in F5 (FFIV) for $1,555,795. Following the Form 4 filing with the SEC, Mehta has control over a total of 7,043 common shares of the company, with 7,043 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1048695/000176472726000008/xslF345X05/wk-form4_1785793325.xml

$FFIV

Insider Trading4d ago

Block Insider Sold Shares Worth $1,469,760, According to a Recent SEC Filing

Anthony Mathew Eisen, Director, on July 30, 2026, sold 18,000 shares in Block (XYZ) for $1,469,760. Following the Form 4 filing with the SEC, Eisen has control over a total of 1,613,672 Class A common shares of the company, with 1,613,672 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1512673/000162828026051998/xslF345X05/wk-form4_1785793083.xml

$XYZ

Insider Trading4d ago

Entrada Therapeutics Insider Sold Shares Worth $807,027, According to a Recent SEC Filing

Kush Parmar, 10% Owner, Director, on July 30, 2026, sold 116,474 shares in Entrada Therapeutics (TRDA) for $807,027. Following the Form 4 filing with the SEC, Parmar has control over a total of 3,939,905 common shares of the company, with 3,939,905 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1689375/000166428126000002/xslF345X05/form4-08032026_090837.xml

$TRDA

Insider Trading4d ago

Jetblue Airways Insider Sold Shares Worth $444,949, According to a Recent SEC Filing

Ursula L Hurley, Chief Financial Officer, on July 30, 2026, sold 77,253 shares in Jetblue Airways (JBLU) for $444,949. Following the Form 4 filing with the SEC, Hurley has control over a total of 211,099 common shares of the company, with 211,099 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1158463/000115846326000082/xslF345X05/wk-form4_1785791914.xml

$JBLU

Insider Trading4d ago

Paccar Insider Sold Shares Worth $261,025, According to a Recent SEC Filing

Brice J Poplawski, Senior Vice President & CFO, on July 31, 2026, sold 1,970 shares in Paccar (PCAR) for $261,025. Following the Form 4 filing with the SEC, Poplawski has control over a total of 19,824 common shares of the company, with 1,391 shares held directly and 18,433 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/75362/000122520826006890/xslF345X05/doc4.xml

$PCAR

Insider Trading4d ago

Paccar Insider Sold Shares Worth $387,908, According to a Recent SEC Filing

Paulo Henrique Bolgar, Vice President, on July 31, 2026, sold 2,897 shares in Paccar (PCAR) for $387,908. Following the Form 4 filing with the SEC, Bolgar has control over a total of 4,743 common shares of the company, with 3,831 shares held directly and 912 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/75362/000122520826006891/xslF345X05/doc4.xml

$PCAR

Insider Trading4d ago

Globe Life Insider Sold Shares Worth $9,121,638, According to a Recent SEC Filing

James Matthew Darden, Director, Co-Chairman & CEO, on July 31, 2026, sold 50,000 shares in Globe Life (GL) for $9,121,638. Following the Form 4 filing with the SEC, Darden has control over a total of 62,653 common shares of the company, with 58,451 shares held directly and 4,202 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/320335/000032033526000214/xslF345X05/form4.xml

$GL

Insider Trading4d ago

Qualcomm Insider Sold Shares Worth $470,528, According to a Recent SEC Filing

Heather S Ace, Executive Vice President, Chief Human Resources Officer, on August 03, 2026, sold 3,200 shares in Qualcomm (QCOM) for $470,528. Following the Form 4 filing with the SEC, Ace has control over a total of 36,535 common shares of the company, with 36,535 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/804328/000080432826000090/xslF345X05/edgardoc.xml

$QCOM

Insider Trading4d ago

Cheesecake Factory Insider Sold Shares Worth $819,021, According to a Recent SEC Filing

Scarlett May, Executive Vice President, General Counsel, on July 31, 2026, sold 7,978 shares in Cheesecake Factory (CAKE) for $819,021. Following the Form 4 filing with the SEC, May has control over a total of 48,946 common shares of the company, with 48,946 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/887596/000130551226000012/xslF345X05/form4-08032026_080803.xml

$CAKE

Insider Trading4d ago

United Therapeutics Insider Sold Shares Worth $4,930,098, According to a Recent SEC Filing

Martine A Rothblatt, Director, Chairperson & CEO, on July 31, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $4,930,098. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000110657826000111/xslF345X05/primarydocument.xml

$UTHR

Insider Trading4d ago

Corecivic Insider Sold Shares Worth $371,750, According to a Recent SEC Filing

Cole G. Carter, Chief Administrative Officer, on August 03, 2026, sold 12,500 shares in Corecivic (CXW) for $371,750. Following the Form 4 filing with the SEC, Carter has control over a total of 190,883 common shares of the company, with 190,883 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1070985/000119312526330684/xslF345X05/ownership.xml

$CXW

Insider Trading4d ago

Marvell Technology Insider Sold Shares Worth $1,805,000, According to a Recent SEC Filing

Chris Koopmans, President and COO, on August 03, 2026, sold 10,000 shares in Marvell Technology (MRVL) for $1,805,000. Following the Form 4 filing with the SEC, Koopmans has control over a total of 227,941 common shares of the company, with 227,941 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1835632/000162828026051905/xslF345X05/wk-form4_1785789180.xml

$MRVL

Insider Trading4d ago

Huntsman Insider Bought Shares Worth $981,000, According to a Recent SEC Filing

Peter R Huntsman, Director, Chairman, President & CEO, on August 03, 2026, executed a purchase for 100,000 shares in Huntsman (HUN) for $981,000. Following the Form 4 filing with the SEC, Huntsman has control over a total of 8,189,669 common shares of the company, with 7,256,341 shares held directly and 933,328 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1307954/000121465926009468/xslF345X05/marketforms-73652.xml

$HUN

Insider Trading4d ago

Verisk Analytics Insider Sold Shares Worth $696,183, According to a Recent SEC Filing

Lee Shavel, Director, Chief Executive Officer, on August 03, 2026, sold 3,535 shares in Verisk Analytics (VRSK) for $696,183. Following the Form 4 filing with the SEC, Shavel has control over a total of 98,490 common shares of the company, with 98,490 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1442145/000119312526330642/xslF345X05/ownership.xml

$VRSK

Insider Trading4d ago

Proqr Therapeutics Insider Bought Shares Worth $353,960, According to a Recent SEC Filing

Daniel Anton de Boer, Director, Chief Executive Officer, on July 31, 2026, executed a purchase for 200,000 shares in Proqr Therapeutics (PRQR) for $353,960. Following the Form 4 filing with the SEC, de Boer has control over a total of 500,000 ordinary shares of the company, with 500,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1612940/000110465926089780/xslF345X05/tm2622051-1_4seq1.xml

$PRQR

Insider Trading4d ago

Amphenol Insider Sold Shares Worth $110,986,719, According to a Recent SEC Filing

Richard Adam Norwitt, Director, President & CEO, on July 31, 2026, sold 686,104 shares in Amphenol (APH) for $110,986,719. Following the Form 4 filing with the SEC, Norwitt has control over a total of 2,795,652 Class A common shares of the company, with 1,931,475 shares held directly and 864,177 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/820313/000110465926089782/xslF345X05/tm2622042-1_4seq1.xml

$APH

Insider Trading4d ago

Nucor Insider Sold Shares Worth $1,019,617, According to a Recent SEC Filing

Stephen D Laxton, President and COO, on July 30, 2026, sold 3,968 shares in Nucor (NUE) for $1,019,617. Following the Form 4 filing with the SEC, Laxton has control over a total of 77,867 common shares of the company, with 77,867 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/73309/000007330926000124/xslF345X05/form4.xmlPrice: $259.19, Change: $+1.90, Percent Change: +0.74%

$NUE

Insider Trading4d ago

Esquire Financial Holdings Insider Sold Shares Worth $388,792, According to a Recent SEC Filing

Robert Mitzman, Director, on July 30, 2026, sold 3,000 shares in Esquire Financial Holdings (ESQ) for $388,792. Following the Form 4 filing with the SEC, Mitzman has control over a total of 144,679 common shares of the company, with 139,679 shares held directly and 5,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1531031/000143774926025369/xslF345X05/rdgdoc.xmlPrice: $131.74, Change: $+2.52, Percent Change: +1.95%

$ESQ

Showing 201-220 of 3112